Search Results - "Zhang, Daoguang"

  • Showing 1 - 12 results of 12
Refine Results
  1. 1

    Discovery of novel pyrazole derivatives as potential anticancer agents in MCL by Ran, Fansheng, Liu, Yang, Zhang, Daoguang, Liu, Meixia, Zhao, Guisen

    Published in Bioorganic & medicinal chemistry letters (01-05-2019)
    “…[Display omitted] Mantle cell lymphoma (MCL) is characterized by the translocation t(11;14) (q13;q32), resulting in the overexpression of cyclin-D1. The…”
    Get full text
    Journal Article
  2. 2

    Recent Developments in Androgen Receptor Antagonists by Ran, Fansheng, Xing, Hualu, Liu, Yang, Zhang, Daoguang, Li, Pengzhan, Zhao, Guisen

    Published in Archiv der Pharmazie (Weinheim) (01-11-2015)
    “…The androgen receptor (AR), a ligand‐dependent transcription factor that regulates the expression of a series of downstream target genes after the binding of…”
    Get full text
    Journal Article
  3. 3

    Discovery of pyrazolopyrimidine derivatives as potent BTK inhibitors with effective anticancer activity in MCL by Ran, Fansheng, Liu, Yang, Liu, Meixia, Zhang, Daoguang, Wang, Peng, Dong, Junze, Tang, Wendi, Zhao, Guisen

    Published in Bioorganic chemistry (01-08-2019)
    “…[Display omitted] •Pyrazolopyrimidine derivatives as potent BTK inhibitors.•12a obtained antiproliferative effects in primary patient tumor cells.•12a showed…”
    Get full text
    Journal Article
  4. 4

    Targeting Bruton's tyrosine kinase for the treatment of B cell associated malignancies and autoimmune diseases: Preclinical and clinical developments of small molecule inhibitors by Zhang, Zhen, Zhang, Daoguang, Liu, Yang, Yang, Dezhi, Ran, Fansheng, Wang, Michael L., Zhao, Guisen

    Published in Archiv der Pharmazie (Weinheim) (01-07-2018)
    “…B cell receptor (BCR) signaling plays a key role in B cell development and function. Aberrant BCR signaling has been confirmed as a central driver for the…”
    Get full text
    Journal Article
  5. 5

    Structural optimization elaborates novel potent Akt inhibitors with promising anticancer activity by Liu, Yang, Yin, Yanzhen, Zhang, Zhen, Li, Carrie J., Zhang, Hui, Zhang, Daoguang, Jiang, Changying, Nomie, Krystle, Zhang, Liang, Wang, Michael L., Zhao, Guisen

    Published in European journal of medicinal chemistry (29-09-2017)
    “…Targeting of Akt has been validated as a well rationalized approach to cancer treatment, and represents a promising therapeutic strategy for aggressive…”
    Get full text
    Journal Article
  6. 6

    Synthesis and biological evaluation of 3-(4-fluorophenyl)-1H-pyrazole derivatives as androgen receptor antagonists by Guo, Guangzhu, Liu, Jianzhen, Wang, Guanjie, Zhang, Daoguang, Lu, Jinjie, Zhao, Guisen

    Published in Anti-cancer drugs (01-04-2016)
    “…A novel series of 3-(4-fluorophenyl)-1H-pyrazole derivatives were synthesized and evaluated for their antiproliferative activity against two prostate cancer…”
    Get full text
    Journal Article
  7. 7

    Discovery of novel 5‐methyl‐1 H ‐pyrazole derivatives as potential antiprostate cancer agents: Design, synthesis, molecular modeling, and biological evaluation by Zhang, Daoguang, Asnake, Solomon, Zhang, Jingya, Olsson, Per‐Erik, Zhao, Guisen

    Published in Chemical biology & drug design (01-06-2018)
    “…Androgen receptor ( AR ) signaling functions as a core driving force for the progression of prostate cancer ( PC a), and AR has been proved to be an effective…”
    Get full text
    Journal Article
  8. 8

    Discovery of novel 5‐methyl‐1H‐pyrazole derivatives as potential antiprostate cancer agents: Design, synthesis, molecular modeling, and biological evaluation by Zhang, Daoguang, Asnake, Solomon, Zhang, Jingya, Olsson, Per‐Erik, Zhao, Guisen

    Published in Chemical biology & drug design (01-06-2018)
    “…Androgen receptor (AR) signaling functions as a core driving force for the progression of prostate cancer (PCa), and AR has been proved to be an effective…”
    Get full text
    Journal Article
  9. 9

    Discovery of novel 5-methyl-1H-pyrazole derivatives as potential anti-prostate cancer agents: design, synthesis, molecular modeling and biological evaluation by Zhang, Daoguang, Asnake, Solomon, Zhang, Jingya, Olsson, Per-Erik, Zhao, Guisen

    Published in Chemical biology & drug design (2018)
    “…Androgen receptor (AR) signaling functions as a core driving force for the progression of prostate cancer (PCa), and AR has been proved to be an effective…”
    Get full text
    Journal Article
  10. 10

    Design, synthesis and biological evaluation of AKT inhibitors bearing a piperidin-4-yl appendant by Zhang, Daoguang, Tong, Dongdong, Yang, Dezhi, Sun, Jing, Zhang, Fenghe, Zhao, Guisen

    Published in MedChemComm (01-08-2018)
    “…A series of AKT inhibitors possessing a piperidin-4-yl side chain was designed and synthesized. Some of them showed high AKT1 inhibitory activity and potent…”
    Get full text
    Journal Article
  11. 11

    Design and discovery of 5-hydroxy-6-oxo-1,6-dihydropyrimidine-4-carboxamide inhibitors of HIV-1 integrase by Zhang, Daoguang, Debnath, Bikash, Yu, Shenghui, Sanchez, Tino Wilson, Christ, Frauke, Liu, Yang, Debyser, Zeger, Neamati, Nouri, Zhao, Guisen

    Published in Bioorganic & medicinal chemistry (01-10-2014)
    “…Raltegravir (RAL) is a first clinically approved integrase (IN) inhibitor for the treatment of HIV but rapid mutation of the virus has led to chemo-resistant…”
    Get full text
    Journal Article
  12. 12

    Design, synthesis, and biological evaluation of 2-(5-methyl-1H-pyrazol-1-yl) acetamide derivatives as androgen receptor antagonists by Dong, Junze, Zhang, Jingya, Li, Zilu, Asnake, Solomon, Zhang, Daoguang, Olsson, Per-Erik, Zhao, Guisen

    Published in Medicinal chemistry research (15-03-2019)
    “…Androgen receptor (AR) signaling is often activated in prostate cancer (PCa) cells, and blockage of this signaling by AR antagonists is an important strategy…”
    Get full text
    Journal Article